Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06160986 · ClinicalTrials.gov registry record · NA

Horizons Chronic Graft-Versus-Host-Disease Study

A NA study of Quality of Life and Graft Vs Host Disease, sponsored by University of Miami.

Active
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06160986 is a NA study of Quality of Life and Graft Vs Host Disease that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 20 participants, below the 453-participant average among 107 other Quality of Life trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06160986, a NA study of Quality of Life and Graft Vs Host Disease, is active but no longer recruiting, sponsored by University of Miami.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This research is being done to evaluate the feasibility of the Horizons Program, a group-based behavioral intervention, to enhance quality of life in patients with chronic graft-versus-host disease.

Interventions

  • BEHAVIORAL Horizons Group Intervention

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2023-12-27
Est. Completion 2025-12-31
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT06160986

The ClinicalTrials.gov registry entry for NCT06160986 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 453-participant average among 107 other Quality of Life trials with a reported enrollment target (96% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Quality of Life appearing as the primary indexed condition, and to 1 intervention - of which Horizons Group Intervention is the first listed.

NCT06160986 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06160986 about?

NCT06160986 is a clinical study titled "Horizons Chronic Graft-Versus-Host-Disease Study". This research is being done to evaluate the feasibility of the Horizons Program, a group-based behavioral intervention, to enhance quality of life in patients with chronic graft-versus-host disease.

What is the current status of trial NCT06160986?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-12-27. Estimated completion is 2025-12-31.

What conditions does trial NCT06160986 study?

This clinical trial studies the following conditions: Quality of Life, Graft Vs Host Disease, Coping Skills, Stem Cell Transplant Complications.

What interventions are being tested in trial NCT06160986?

The interventions under investigation include: Horizons Group Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06160986?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06160986 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.